SCHEMBL3208633

SCHEMBL3208633

Cc1cc(Br)cc2c(=O)oc(=O)[nH]c12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.38
F2 P00734 1/20 0.37
CFD P00746 1/20 0.37
MAOA P21397 3/20 0.36
MAOB P27338 3/20 0.36
RAB9A P51151 1/20 0.36
ESR2 Q92731 4/20 0.35
PDGFRA P16234 1/20 0.33
MAPK8 P45983 1/20 0.33
CDK5 Q00535 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
LMNA P02545 1/20 0.33
HPGD P15428 1/20 0.33
ESR1 P03372 3/20 0.33
NOS1 P29475 2/20 0.32
NOS3 P29474 1/20 0.32
NOS2 P35228 1/20 0.32
PARP1 P09874 1/20 0.32
PARP2 Q9UGN5 1/20 0.32
PARP4 Q9UKK3 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5280067 0.82 ABCB1 (0.46) F2CFDMAOAMAOBESR2
SCHEMBL639250 0.82 RAB9A (0.41) F2CFDMAOAMAOBRAB9A
SCHEMBL30398232 0.82 RAB9A (0.41) F2CFDMAOAMAOBRAB9A
SCHEMBL2906293 0.79 F2 (0.37) F2CFDMAOAMAOBPDGFRA
SCHEMBL30087001 0.79 LMNA (0.38) F2CFDMAOAMAOBRAB9A
SCHEMBL14698260 0.79 MAOA (0.39) F2CFDMAOAMAOBRAB9A
SCHEMBL13208799 0.79 F2 (0.37) F2CFDMAOAMAOBRAB9A
SCHEMBL634152 0.79 LMNA (0.38) F2CFDMAOAMAOBRAB9A
SCHEMBL14698434 0.79 F2 (0.37) F2CFDMAOAMAOBPDGFRA
SCHEMBL20350863 0.79 MAOB (0.38) F2CFDMAOAMAOBESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250368602-A1 PROCESS FOR PREPARING CYANO SUBSTITUTED ANTHRANILIC DIAMIDES AND INTERMEDIATES THEREOF PI INDUSTRIES LTD. (IN) 2025-12-04 US disclosed
CN-113692406-B Process for preparing anthranilamide compounds and intermediates thereof PI工业有限公司 2024-07-23 CN disclosed
WO-2024105700-A1 A METHOD FOR THE SYNTHESIS OF ANTHRANILIC AMIDE COMPOUNDS AND INTERMEDIATES THEREOF PI INDUSTRIES LTD. (IN) 2024-05-23 WO disclosed
US-20230339844-A1 A PROCESS FOR THE SYNTHESIS OF ANTHRANILIC ACID/AMIDE COMPOUNDS AND INTERMEDIATES THEREOF PI INDUSTRIES LTD. (IN) 2023-10-26 US disclosed
CN-116670115-A Process for preparing anthranilic acid/anthranilic acid amide compounds and intermediates thereof 皮埃企业有限公司 2023-08-29 CN disclosed
EP-4214188-A1 A PROCESS FOR THE SYNTHESIS OF ANTHRANILIC ACID/AMIDE COMPOUNDS AND INTERMEDIATES THEREOF PI Industries Ltd. (IN) 2023-07-26 EP disclosed
WO-2022058916-A1 A PROCESS FOR THE SYNTHESIS OF ANTHRANILIC ACID/AMIDE COMPOUNDS AND INTERMEDIATES THEREOF PI INDUSTRIES LIMITED (IN) 2022-03-24 WO disclosed
CN-113692406-A Process for preparing o-formamido-benzamide compounds and intermediates thereof PI工业有限公司 2021-11-23 CN disclosed
US-9556141-B2 Process for preparing N-substituted 1H-pyrazole-5-carboxylate compounds and derivatives thereof BASF SE (DE) 2017-01-31 US disclosed
US-9282741-B2 Aniline type compounds BASF SE (DE) 2016-03-15 US disclosed
WO-2013024008-A1 ANILINE TYPE COMPOUNDS BASF SE (DE) 2013-02-21 WO disclosed
CN-101337959-B 2-amino-N-oxybenzamidecompounds with insecticidal activity NAT PESTICIDE DISCOVERY ENGINEERING RES CT 2011-09-07 CN disclosed
US-7683201-B2 Quinazoline(di)ones for invertebrate pest control E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-03-23 US disclosed
CN-101337959-A 2-amino-N-oxybenzamidecompounds with insecticidal activity NAT PESTICIDE DISCOVERY ENGINE (CN) 2009-01-07 CN disclosed
US-7241767-B2 Quinazoline(di)ones for invertebrate pest control E. I. DU PONT DE NEMOURS AND COMPANY (US) 2007-07-10 US disclosed
US-20060194961-A1 Quinazoline(di)ones for invertebrate pest control FMC CORPORATION 2006-08-31 US disclosed
US-20050124600-A1 Quinazoline(di)ones for invertebrate pest control E. I. DU PONT DE NEMOURS AND COMPANY 2005-06-09 US disclosed
US-6884801-B1 Imidazoline derivatives as alpha-1A adrenoceptor ligands SMITHKLINE BEECHAM CORPORATION (US) 2005-04-26 US disclosed
EP-1175406-A1 IMIDAZOLINE DERIVATIVES AS ALPHA-1A ADRENOCEPTOR LIGANDS GLAXO GROUP LIMITED (GB) 2002-01-30 EP disclosed
WO-2000066563-A1 IMIDAZOLINE DERIVATIVES AS ALPHA-1A ADRENOCEPTOR LIGANDS GLAXO GROUP LIMITED (GB) 2000-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250368602-A1 PROCESS FOR PREPARING CYANO SUBSTITUTED ANTHRANILIC DIAMIDES AND INTERMEDIATES THEREOF QDPR, IDH3B, CYB5R3 GSK3B 2155/4885F2 807/4885CFD 3286/4885
US-20050124600-A1 Quinazoline(di)ones for invertebrate pest control DDT, BRS3, F12 GSK3B 4312/4885F2 92/4885CFD 971/4885
US-20230339844-A1 A PROCESS FOR THE SYNTHESIS OF ANTHRANILIC ACID/AMIDE COMPOUNDS AND INTERMEDIATES THEREOF ASS1, ACMSD, ADCY10 GSK3B 4124/4885F2 538/4885CFD 4456/4885
US-20060194961-A1 Quinazoline(di)ones for invertebrate pest control F12, DDT, SBK3 GSK3B 4446/4885F2 41/4885CFD 740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.